BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 34388982)

  • 1. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
    Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
    BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
    Yongzhi X
    Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
    Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
    Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophagocytic syndrome and COVID-19.
    Retamozo S; Brito-Zerón P; Sisó-Almirall A; Flores-Chávez A; Soto-Cárdenas MJ; Ramos-Casals M
    Clin Rheumatol; 2021 Apr; 40(4):1233-1244. PubMed ID: 33389315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series.
    Hansen S; Alduaij W; Biggs CM; Belga S; Luecke K; Merkeley H; Chen LYC
    Eur J Haematol; 2021 May; 106(5):654-661. PubMed ID: 33523540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?].
    Alfaro-Murillo A; Lazo-Paéz G
    Rev Chilena Infectol; 2021 Apr; 38(2):271-278. PubMed ID: 34184718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
    Opoka-Winiarska V; Grywalska E; Roliński J
    BMC Med; 2020 Jul; 18(1):214. PubMed ID: 32664932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of Hemophagocytic lymphohistiocytosis induced by COVID-19, and review of all cases reported in the literature.
    Kayaaslan BU; Asilturk D; Eser F; Korkmaz M; Kucuksahin O; Pamukcuoglu M; Guner R
    J Infect Dev Ctries; 2021 Nov; 15(11):1607-1614. PubMed ID: 34898486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophagocytic lymphohistiocytosis in an adult with postacute COVID-19 syndrome.
    Wiseman D; Lin J; Routy JP; Samoukovic G
    BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34518190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
    Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
    BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.
    Dandu H; Yadav G; Malhotra HS; Pandey S; Sachu R; Dubey K
    Int J Lab Hematol; 2021 Dec; 43(6):1291-1301. PubMed ID: 34086418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
    Kessel C; Vollenberg R; Masjosthusmann K; Hinze C; Wittkowski H; Debaugnies F; Nagant C; Corazza F; Vély F; Kaplanski G; Girard-Guyonvarc'h C; Gabay C; Schmidt H; Foell D; Tepasse PR
    Arthritis Rheumatol; 2021 Oct; 73(10):1791-1799. PubMed ID: 33880885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.
    Schnaubelt S; Tihanyi D; Strassl R; Schmidt R; Anders S; Laggner AN; Agis H; Domanovits H
    Medicine (Baltimore); 2021 Mar; 100(12):e25170. PubMed ID: 33761694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary Hemophagocytic Lymphohistiocytosis in a Neonate with SARS-CoV-2 Infection.
    El-Isa HZ; Khader OA; Khader M; Ashour BA; Azzam MI; Badran EF
    Am J Case Rep; 2022 Jan; 23():e934839. PubMed ID: 35087017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) coinfected with COVID-19 complicated by hemophagocytic lymphohistiocytosis: a case report.
    Li M; Li F; Dai Y; Zeng YZ; Chen X
    Front Immunol; 2024; 15():1371490. PubMed ID: 38686382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
    Liu JM; Chi J
    Exp Biol Med (Maywood); 2022 Feb; 247(4):330-337. PubMed ID: 35068219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
    Prilutskiy A; Kritselis M; Shevtsov A; Yambayev I; Vadlamudi C; Zhao Q; Kataria Y; Sarosiek SR; Lerner A; Sloan JM; Quillen K; Burks EJ
    Am J Clin Pathol; 2020 Sep; 154(4):466-474. PubMed ID: 32681166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.
    Hakim NN; Chi J; Olazagasti C; Liu JM
    Exp Biol Med (Maywood); 2021 Jan; 246(1):5-9. PubMed ID: 32972235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis.
    Chu R; van Eeden C; Suresh S; Sligl WI; Osman M; Cohen Tervaert JW
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.